2009•Cancer Nursing PracticeRequires access

Vesicant chemotherapy – the management of extravasation

Lisa Schulmeister

Open publisher page 4 citations

Abstract

Lisa Schulmeister describes evidence-based treatment for tissue necrosis, which can result when vesicant chemotherapy agents extravasate from the vein

About this research paper

What this paper is about

Lisa Schulmeister describes evidence-based treatment for tissue necrosis, which can result when vesicant chemotherapy agents extravasate from the vein

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Lisa Schulmeister describes evidence-based treatment for tissue necrosis, which can result when vesicant chemotherapy agents extravasate from the vein

Key concepts: Extravasation, Chemotherapy, Tissue necrosis, Medicine, Vein, Necrosis, Surgery, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Vesicant chemotherapy – the management of extravasation — Research Paper | ScholarLens